An interesting finding was the observation of the highest coexpression of CD38 and HLA-DR on CD4+ cells in SLE patients in agreement with recent studies describing that increased CD38 expression in T-cells was more prevalent in clinically active SLE [29]. The gene discussed is CD4; the disease is systemic lupus erythematosus.